DRUG
type-II kinase inhibitors
1 hypothesis across 1 therapeutic domain
ALL HYPOTHESES
Repurposing candidates for type-II kinase inhibitors
Pancreatic cancer 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| EGFR | pancreatic ductal adenocarcinoma | 0.208 | Mid | novel signal | preclinical only |